Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids
Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids
Rationale: patients with severe asthma are dependent upon treatment with high doses of inhaled corticosteroids (ICS) and often also oral corticosteroids (OCS). The extent of endogenous androgenic anabolic steroid (EAAS) suppression in asthma has not previously been described in detail. The objective of the present study was to measure urinary concentrations of EAAS in relation to exogenous corticosteroid exposure.
Methods: urine collected at baseline in the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcomes) study of severe adult asthmatics (SA, n=408) was analysed by quantitative mass spectrometry. Data were compared to that of mild-to-moderate asthmatics (MMA, n=70) and healthy subjects (HC, n=98) from the same study.
Measurements and main results : the concentrations of urinary endogenous steroid metabolites were substantially lower in SA than in MMA or HC. These differences were more pronounced in SA patients with detectable urinary OCS metabolites. Their dehydroepiandrosterone sulfate (DHEA-S) concentrations were <5% of those in HC, and cortisol concentrations were below the detection limit in 75% of females and 82% of males. The concentrations of EAAS in OCS-positive patients, as well as patients on high-dose ICS only, were more suppressed in females than males (p<0.05). Low levels of DHEA were associated with features of more severe disease and were more prevalent in females (p<0.05). The association between low EAAS and corticosteroid treatment was replicated in 289 of the SA patients at follow-up after 12-18 months.
Conclusion: the pronounced suppression of endogenous anabolic androgens in females might contribute to sex differences regarding the prevalence of severe asthma.
Yasinska, Valentyna
6f9963b5-11bb-4461-bc45-dea5d0dfbe2b
Gómez, Cristina
d1751750-3b59-4f7d-9911-4f857a597788
Kolmert, Johan
3c5321ae-faa5-44ac-9975-f4c8efd55801
Howarth, Peter H.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Skipp, Paul
1ba7dcf6-9fe7-4b5c-a9d0-e32ed7f42aa5
Yasinska, Valentyna
6f9963b5-11bb-4461-bc45-dea5d0dfbe2b
Gómez, Cristina
d1751750-3b59-4f7d-9911-4f857a597788
Kolmert, Johan
3c5321ae-faa5-44ac-9975-f4c8efd55801
Howarth, Peter H.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Skipp, Paul
1ba7dcf6-9fe7-4b5c-a9d0-e32ed7f42aa5
Yasinska, Valentyna, Gómez, Cristina and Kolmert, Johan
,
et al.
(2023)
Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids.
ERJ Open Research, 9 (5).
(doi:10.1183/23120541.00269-2023).
Abstract
Rationale: patients with severe asthma are dependent upon treatment with high doses of inhaled corticosteroids (ICS) and often also oral corticosteroids (OCS). The extent of endogenous androgenic anabolic steroid (EAAS) suppression in asthma has not previously been described in detail. The objective of the present study was to measure urinary concentrations of EAAS in relation to exogenous corticosteroid exposure.
Methods: urine collected at baseline in the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcomes) study of severe adult asthmatics (SA, n=408) was analysed by quantitative mass spectrometry. Data were compared to that of mild-to-moderate asthmatics (MMA, n=70) and healthy subjects (HC, n=98) from the same study.
Measurements and main results : the concentrations of urinary endogenous steroid metabolites were substantially lower in SA than in MMA or HC. These differences were more pronounced in SA patients with detectable urinary OCS metabolites. Their dehydroepiandrosterone sulfate (DHEA-S) concentrations were <5% of those in HC, and cortisol concentrations were below the detection limit in 75% of females and 82% of males. The concentrations of EAAS in OCS-positive patients, as well as patients on high-dose ICS only, were more suppressed in females than males (p<0.05). Low levels of DHEA were associated with features of more severe disease and were more prevalent in females (p<0.05). The association between low EAAS and corticosteroid treatment was replicated in 289 of the SA patients at follow-up after 12-18 months.
Conclusion: the pronounced suppression of endogenous anabolic androgens in females might contribute to sex differences regarding the prevalence of severe asthma.
Text
00269-2023.full
- Version of Record
More information
Accepted/In Press date: 21 June 2023
e-pub ahead of print date: 2 October 2023
Identifiers
Local EPrints ID: 487956
URI: http://eprints.soton.ac.uk/id/eprint/487956
ISSN: 2312-0541
PURE UUID: 8dd34a40-b20e-4f3a-8e8a-748525ad7351
Catalogue record
Date deposited: 11 Mar 2024 17:48
Last modified: 12 Jul 2024 01:33
Export record
Altmetrics
Contributors
Author:
Valentyna Yasinska
Author:
Cristina Gómez
Author:
Johan Kolmert
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics